PATH
Menu

John Boslego

John Boslego leads our work in vaccine development. Photo: PATH.

Program Leader, Vaccine Development

John Boslego, MD, directs PATH’s vaccine development program, which seeks to identify and facilitate the development of safe, effective, affordable vaccines against select major disease threats in the developing world.

Dr. Boslego’s career spans 30 years of service to private industry and the United States government. Before joining PATH, he served as executive director of Biologics, Clinical Research, at Merck & Co., Inc. His portfolio at Merck included clinical development of a Haemophilus influenzae type b conjugate vaccine, a recombinant hepatitis B vaccine, an influenza DNA vaccine, a pneumococcal polysaccharide vaccine, a pneumococcal conjugate vaccine, various pediatric combination vaccines, a rotavirus vaccine, and a human papillomavirus vaccine.

For nearly two decades, Dr. Boslego worked for the Walter Reed Army Institute of Research in vaccine research—both in the laboratory and in clinical trials. He also directed the Armed Forces Research Institute of Medical Sciences in Thailand for three years.

Dr. Boslego received his medical education at George Washington University after graduating from the United States Military Academy.